Muna Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, with an emphasis on resilience-based approaches to protect brain function. The company leverages an all-in-human discovery engine to identify and develop orally administered small molecules, including TREM2 agonists, to slow or stop progression of Alzheimer’s disease and related disorders.
Leadership & Board
Current Number of Employees58
Current LinkedIn Followers9,643
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$1M
Total Amount Raised$1M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$1M
Latest Funding Amount$1M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Muna Therapeutics had 58 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
58Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Muna Therapeutics had 9,643 followers as of September 14, 2026. The number of followers increased by 45 (0.47%) week-over-week.
9,643Latest Followers Count
45(0.47%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.